DEVICES AND METHODS FOR DELIVERING SUBTANCES FOR IMPROVED WELLBEING

• US 20180264241A1
• Filed: 03/20/2017
• Published: 09/20/2018
• Est. Priority Date: 03/20/2017
• Status: Active Application

• Current Assignee: Alan Backus, Donald Plance
• Original Assignee: Alan Backus
• Inventors: PLANCE, Donald, BACKUS, Alan
• Application Number:
  US15/463,466
• Publication Number:
  US 20180264241A1
• Time in Patent Office: Days
• CPC Class Codes: A61J 7/003 Sticks, e.g. lollipops with drug release
• CPC Class Codes: A61J 7/0053 Syringes, pipettes or oral dispensers
• CPC Class Codes: A61K 9/0043 Nose
• CPC Class Codes: A61K 9/0046 Ear
• CPC Class Codes: A61K 9/006 Oral mucosa, e.g. mucoadhesive forms, sublingual droplets; Buccal patches or films; Buccal sprays
• CPC Class Codes: A61M 15/08 Inhaling devices inserted into the nose
• CPC Class Codes: A61M 2021/0016 by the smell sense
• CPC Class Codes: A61M 21/02 for inducing sleep or relaxation, e.g. by direct nerve stimulation, hypnosis, analgesia for massage A61H; electrotherapy A61N, e.g. applying alternating or intermittent electric currents for producing anaesthesia A61N1/36021
• CPC Class Codes: A61M 2209/06 Packaging for specific medical equipment
• CPC Class Codes: A61M 2210/0618 Nose
• CPC Class Codes: A61M 2210/0662 Ears
• CPC Class Codes: A61M 31/002 Devices for releasing a drug at a continuous and controlled rate for a prolonged period of time artificial gland structures or devices A61F2/022; intra-uterine contraceptive devices A61F6/14; tampons for introducing into the vagina A61F13/20, A61L15/00; suppositories or bougies for intra-vaginal or intra-uterine application A61K9/02; physical forms of medicinal preparations for sustained or differential drug release A61K9/20, A61K9/50

Abstract

A method and apparatus to deliver biological altering substances through body cavities including ears, nose, mouth, anus and vagina, utilizing at least osmotic, olfactory and inhaling transfusion of active ingredients includes a first reservoir configured to be disposed against sublingual surfaces and hold a first drug. The device is configured to transmit the first drug through sublingual surfaces into the bloodstream. A second reservoir, coupled to the first reservoir, is disposed below a nostril, and configured to hold a substance and transmit the substance into air passing from the exterior of the nostril into the nasal cavity.

Claims

1. A drug delivery device comprising:

a plug configured for insertion into an ear canal and contacting inner surfaces thereof;

the plug further configured to transmit an associated drug from the plug, through inner surfaces of the ear canal, into the bloodstream.

2. The drug delivery device of claim 1, further including the plug configured with a cavity configured such that air freely passes through it when inserted into an ear canal.

3. The drug delivery device of claim 1, wherein the plug includes an orifice penetrating through it, and the orifice, when the plug is inserted into an ear canal, is configured to promote free passage of air through the plug, from an exterior of an ear into interior portions of the ear canal.

4. The drug delivery device of claim 2, further including the plug being constructed from open cell foam.

5. The drug deliveries device of claim 2, further including the plug being constructed from a fibrous material.

6. The drug delivery device of claim 1, further including the plug further configured to pass sound to freely when the plug is inserted into an ear canal.

7. The drug delivery device of claim 1, further including the plug being constructed from a generally flat sheet which is rolled into a tube.

8. The drug delivery device of claim 1, further including the plug being constructed of a resilient material.

9. The drug delivery device of claim 1, further including the plug having an end portion which is tapered inward toward its terminus, and the end portion being configured to be inserted into an ear canal.

10. A drug delivery device including:

a plug configured for insertion into a nostril and contacting inner surfaces of the nasal cavity posterior to the nostril;

a first drug carried by the plug, and configured to transmit from the plug, through inner surfaces of the nasal cavity, into the bloodstream.

11. The drug delivery device of claim 10, further including the plug further configured to promote free passage of air through it when inserted into a nostril.

12. The drug delivery device of claim 10, further including the plug having a disposed orifice, and the orifice, when the plug is inserted into a nostril, configured to allow air to pass through the plug, from the exterior of the nostril into interior portions of the nasal cavity.

13. The drug delivery device of claim 11, further including the plug being constructed from open cell foam.

14. The drug deliveries device of claim 11, further including the plug being constructed from a fibrous material.

15. The drug delivery device of claim 10, further including the plug being constructed from a generally flat sheet which is rolled into a tube.

16. The drug delivery device of claim 10, further including the plug being constructed of a resilient material.

17. The drug delivery device of claim 10, further including the plug having an end portion which is tapered inward toward its terminus, and the end portion being configured to be inserted into a nostril.

18. The drug delivery device of claim 10, wherein, when the plug is inserted into a nostril, the plug is configured to pass air from the exterior of the nostril, through the plug, to the nasal cavity posterior of the nostril, and the plug includes a reservoir holding a substance, and the reservoir configured to transmit the substance from the reservoir into air passing through the plug.

19. The drug delivery device of claim 18, wherein the reservoir is configured to hold a second drug which affects specific biological functions, and wherein the first drug effects specific biological functions, and at least some of the specific biological functions affected by the second drug are the same as the specific biological functions affected by the first drug.

20. The drug delivery device of claim 18, wherein the substance held by the reservoir is a second drug which affects specific biological functions, and the first drug affects specific biological functions, and at least some of the specific biological functions affected by the second drug are different than the specific biological functions affected by the first drug.

21. A drug delivery device, including:

an extensive member configured to extend into the mouth and be disposed against sublingual surfaces;

the extensive member holding a first drug, and being configured to transmit the first drug through sublingual surfaces into the bloodstream;

a reservoir configured to be disposed between upper and lower oral lips, and configured to hold a substance, and configured to transmit the substance into air passing from the exterior of the lips into the oral cavity;

the extensive member being coupled to the reservoir.

22. The drug delivery device of claim 21, further including instructions to insert the extensive member beneath the tongue.

23. A drug delivery device, including:

a first reservoir configured to be disposed against sublingual surfaces;

the first reservoir holding a first drug, and being configured to transmit the first drug through sublingual surfaces into the bloodstream;

a second reservoir configured to be disposed below a nostril, and configured to hold a substance, and configured to transmit the substance into air passing from the exterior of the nostril into the nasal cavity;

the first reservoir being coupled to the second reservoir.

24. The drug delivery device of claim 23 further including a restraint, configured to rest anterior of front teeth, and the restraint disposed intermediate of the first reservoir and the second reservoir, and the restraint being coupled to both the first reservoir and the second reservoir.

25. The drug delivery device claim 24, wherein there is a member connecting the first reservoir to second reservoir, and the restraint slides along the member.

26. A drug delivery device, including:

a first reservoir, holding a first drug and configured to be disposed sublingually;

the first reservoir configured to transfer the first drug, through sublingual surfaces and into the bloodstream;

a shaft projecting from the first reservoir;

a second reservoir, holding a substance and the second reservoir configured to be disposed along the shaft and below a nostril;

the second reservoir configured to transfer the substance into air passing into the nostril.

27. The drug delivery device of claim 26, wherein the first reservoir is configured so as to resemble the head of a lollipop.

28. The drug delivery device of claim 26, wherein the first reservoir is configured to hold an associated flavoring.

29. The drug delivery device of claim 26, further including the first reservoir configured so as to promote dissolving via saliva.

30. The drug delivery device of claim 26, further including the first reservoir configured so as to retard dissolving in saliva.

31. The drug delivery device of claim 26, wherein the second reservoir is configured to slide along the shaft.

32. The drug delivery device of claim 26, further including the shaft being constructed of material which is non-permeable to both the first drug and to the substance.

33. The drug delivery device of claim 26, further including a skin which is either semi-permeable or non-permeable to the first drug, and the skin covering at least a portion of the first reservoir.

34. The drug delivery device of claim 26, further including packaging which is constructed of material non-permeable to the first drug and non-permeable to the substance, and the packaging forming a sealed enclosure around the first reservoir, and the packaging forming a sealed enclosure around the second reservoir, and the packaging separating the first reservoir from the second reservoir.

35. The drug delivery device of claim 26, further including the substance being a drug.

36. The drug delivery device of claim 26, wherein the substance is a drug which is different than the first drug.

37. The drug delivery device of claim 26 further including instructions to place the first reservoir below the tongue.